Close
05 Aug 2024
Revised guidelines published today by the Pharmacy Board of Australia provide greater clarity and direction on safe practice when compounding medicines.
The Guidelines on compounding of medicines provide updated guidance on when it may be appropriate to compound a medicine, supported by a revised definition of a ‘commercial medicine’.
Other changes include:
The revised guidelines also reaffirm longstanding guidance for pharmacists about when not to compound a medicine, including if:
Additional resources
Along with the revised guidelines, the Board has published a consumer fact sheet which can be used by pharmacists in practice to inform consumers about how a compounded medicine is different to other medicines.
The Board has also updated the document containing background information on the regulation of compounding by pharmacists, which is set out in relevant legislation and administered by other regulatory bodies. It provides an explanation of the regulatory environment in which the Board’s Guidelines on compounding of medicines should be applied by pharmacists when compounding medicines.
The FAQ for pharmacists on the compounding of medicines and other published resources will be reviewed and updated by 1 October 2024.
The new guidelines come into effect from 1 October 2024. You can access the guidelines and more information about pharmacy and compounding at the Pharmacy Board of Australia’s website.